Prospective Grant of Exclusive License: Family Healthware, 20823 [2012-8291]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 67 / Friday, April 6, 2012 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Public Health Preparedness and
Response (BSC, OPHPR)
mstockstill on DSK4VPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates: 10:30 a.m.–6 p.m., May
1, 2012; 9 a.m.–3:45 p.m., May 2, 2012.
Place: CDC, 1600 Clifton Road, NE., Roybal
Campus, Atlanta, Georgia 30329. May 1,
2012: Building 19, Room 254/255. May 2,
2012: Building 21, Room 1204A/1204B.
Status: Open to the public limited only by
the space available. The meeting room will
accommodate up to 75 people. Public
participants should pre-register for the
meeting as described in Additional
Information for Public Participants.
Purpose: This Board is charged with
providing advice and guidance to the
Secretary, Department of Health and Human
Services (HHS), the Assistant Secretary for
Health (ASH), the Director, Centers for
Disease Control and Prevention (CDC), and
the Director, Office of Public Health
Preparedness and Response (OPHPR),
concerning strategies and goals for the
programs and research within OPHPR,
monitoring the overall strategic direction and
focus of the OPHPR Divisions and Offices,
and administration and oversight of peer
review of OPHPR scientific programs. For
additional information about the Board,
please visit: https://www.cdc.gov/phpr/
science/counselors.htm.
Matters To Be Discussed: Agenda items for
this meeting include: (1) Briefings and BSC
deliberation on the following topics: CDC
Laboratory Preparedness; OPHPR Research
Portfolio Budget; CDC’s Preparedness Index;
Novel Approaches to Anti-Viral Delivery;
CDC’s Anthrax Management Team;
Estimating the Cost of Preparedness; (2)
Programmatic responses to BSC-approved
recommendations resulting from external
peer review of: The Career Epidemiology
Field Officer (CEFO) Program and the
Preparedness and Emergency Response
Research Centers (PERRCs) program; (3) BSC
liaison representative updates to the Board
highlighting organizational activities relevant
to the OPHPR mission; (4) a discussion of a
proposed ad hoc working group to review the
Division of Strategic National Stockpile
(DSNS).
Agenda items are subject to change as
priorities dictate.
Additional Information for Public
Participants: Members of the public that wish
to attend this meeting should pre-register by
submitting the following information by
email, facsimile, or phone (see Contact
Person for More Information) no later than
12:00 noon (EDT) on Monday, April 20, 2012:
• Full Name,
VerDate Mar<15>2010
16:17 Apr 05, 2012
Jkt 226001
• Organizational Affiliation,
• Complete Mailing Address,
• Citizenship, and
• Phone Number or Email Address
Contact Person for More Information: Carol
Marsh, OPHPR BSC Coordinator, Centers for
Disease Control and Prevention, 1600 Clifton
Road, NE., Mailstop D–44, Atlanta, Georgia
30333, Telephone: (404) 639–4773;
Facsimile: (404) 639–7977; Email:
OPHPR.BSC.Questions@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: March 30, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–8290 Filed 4–5–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Prospective Grant of Exclusive
License: Family Healthware
Technology Transfer Office,
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services.
ACTION: Notice.
AGENCY:
This is a notice in accordance
with 35 U.S.C. 209(e) and 37 CFR
404.7(a)(1)(i) that the Centers for Disease
Control and Prevention (CDC),
Technology Transfer Office, Department
of Health and Human Services (DHHS),
is contemplating the grant of a
worldwide, exclusive license to practice
the inventions embodied in the patent
application referred to below to Sanitas
Inc., having a place of business in La
Jolla, California. The patent rights in
these inventions have been assigned to
the government of the United States of
America. The patent application(s) to be
licensed are:
SUMMARY:
US Patent Application 11/815,445 entitled
‘‘Personal Assessment Including Familial
Risk Analysis for Personalized Disease
Prevention Plan,’’ filed 5/20/2008, claiming
priority to Provisional Patent Application No.
60/650,076, filed 2/3/2005. CDC Technology
ID No. I–004–04.
Status: Patent Application Pending.
Priority Date: 2/3/2005.
Issue Date: N/A.
The prospective exclusive license will
be royalty-bearing and will comply with
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
20823
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7.
Technology: This technology provides
a computer-based familial risk
assessment tool. It involves a three-step
process which uses the disease history
of a person’s first and second-degree
relatives to assess the risk of common
diseases of adulthood in order to
influence early disease detection and
prevention strategies.
ADDRESSES: Requests for a copy of this
patent application, inquiries, comments,
and other materials relating to the
contemplated license should be directed
to Donald Prather, J.D., Ph.D.,
Technology Licensing and Marketing
Specialist, Technology Transfer Office,
Centers for Disease Control and
Prevention (CDC), 4770 Buford
Highway, Mailstop K–79, Atlanta, GA
30341, Telephone: (770) 488–8612;
Facsimile: (770) 488–8615. Applications
for a license filed in response to this
notice will be treated as objections to
the grant of the contemplated license.
Only written comments and/or
applications for a license which are
received by CDC within thirty days of
this notice will be considered.
Comments and objections submitted in
response to this notice will not be made
available for public inspection, and, to
the extent permitted by law, will not be
released under the Freedom of
Information Act, 5 U.S.C. 552.
Dated: March 27, 2012.
Tanja Popovic,
Deputy Associate Director for Science Centers
for Disease Control and Prevention.
[FR Doc. 2012–8291 Filed 4–5–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0332]
Jyotin Parikh: Debarment Order
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is issuing an
order under the Federal Food, Drug, and
Cosmetic Act (the FD&C Act) debarring
Jyotin Parikh for 5 years from providing
services in any capacity to a person that
has an approved or pending drug
product application. FDA bases this
order on a finding that Mr. Parikh was
convicted of one count of conspiracy to
commit an offense against the United
States for conduct relating to the
SUMMARY:
E:\FR\FM\06APN1.SGM
06APN1
]]>Agencies
[Federal Register Volume 77, Number 67 (Friday, April 6, 2012)]
[Notices]
[Page 20823]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-8291]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Prospective Grant of Exclusive License: Family Healthware
AGENCY: Technology Transfer Office, Centers for Disease Control and
Prevention (CDC), Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This is a notice in accordance with 35 U.S.C. 209(e) and 37
CFR 404.7(a)(1)(i) that the Centers for Disease Control and Prevention
(CDC), Technology Transfer Office, Department of Health and Human
Services (DHHS), is contemplating the grant of a worldwide, exclusive
license to practice the inventions embodied in the patent application
referred to below to Sanitas Inc., having a place of business in La
Jolla, California. The patent rights in these inventions have been
assigned to the government of the United States of America. The patent
application(s) to be licensed are:
US Patent Application 11/815,445 entitled ``Personal Assessment
Including Familial Risk Analysis for Personalized Disease Prevention
Plan,'' filed 5/20/2008, claiming priority to Provisional Patent
Application No. 60/650,076, filed 2/3/2005. CDC Technology ID No. I-
004-04.
Status: Patent Application Pending.
Priority Date: 2/3/2005.
Issue Date: N/A.
The prospective exclusive license will be royalty-bearing and will
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
Technology: This technology provides a computer-based familial risk
assessment tool. It involves a three-step process which uses the
disease history of a person's first and second-degree relatives to
assess the risk of common diseases of adulthood in order to influence
early disease detection and prevention strategies.
ADDRESSES: Requests for a copy of this patent application, inquiries,
comments, and other materials relating to the contemplated license
should be directed to Donald Prather, J.D., Ph.D., Technology Licensing
and Marketing Specialist, Technology Transfer Office, Centers for
Disease Control and Prevention (CDC), 4770 Buford Highway, Mailstop K-
79, Atlanta, GA 30341, Telephone: (770) 488-8612; Facsimile: (770) 488-
8615. Applications for a license filed in response to this notice will
be treated as objections to the grant of the contemplated license. Only
written comments and/or applications for a license which are received
by CDC within thirty days of this notice will be considered. Comments
and objections submitted in response to this notice will not be made
available for public inspection, and, to the extent permitted by law,
will not be released under the Freedom of Information Act, 5 U.S.C.
552.
Dated: March 27, 2012.
Tanja Popovic,
Deputy Associate Director for Science Centers for Disease Control and
Prevention.
[FR Doc. 2012-8291 Filed 4-5-12; 8:45 am]
BILLING CODE 4163-18-P
